The effect of the BNT162b2 vaccine on antinuclear antibody and antiphospholipid antibody levels

The Food and Drug Administration (FDA) approved the first SARS-CoV-2 mRNA vaccine (Pfizer-BioNTech) in December 2020. New adverse events have emerged since these vaccines have reached market. Although no clear association between messenger ribonucleic acid (mRNA) vaccines and autoimmunity has emerge...

Descripción completa

Detalles Bibliográficos
Autores principales: Noureldine, Hussein A., Maamari, Julian, El Helou, Mohamad Othman, Chedid, Georges, Farra, Anna, Husni, Roula, Mokhbat, Jacques E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385410/
https://www.ncbi.nlm.nih.gov/pubmed/35978253
http://dx.doi.org/10.1007/s12026-022-09309-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385410/
https://www.ncbi.nlm.nih.gov/pubmed/35978253
http://dx.doi.org/10.1007/s12026-022-09309-5

Ejemplares similares